Clinical trial

JAB-3068 Activity in Adult Patients With Advanced Solid Tumors

NCT04721223

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-04-26

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2021-04-26Date precision: day

Registry last updated2024-09-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Solid Tumorunresolved

Esophageal Squamous Cell Carcinomaunresolved

Non Small Cell Lung Cancerunresolved

Head and Neck Squamous Cell Carcinomaunresolved

Interventions

PD1 inhibitorDRUG

Sponsors & collaborators

Jacobio Pharmaceuticals Co., Ltd.lead sponsor

AbbViecollaborator

Mapped research locations

BeijingBeijing Municipality, China2 ZhengzhouHenan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04721223 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.